NASH

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) lost around one quarter of their value Thursday and another 7 percent early Friday morning in reaction to a concerning U.S. Food and Drug Administration letter sent to doctors regarding its liver treatment product called Ocaliva for the...

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) jumped nearly 10 percent early Friday morning after the company provided an update on an ongoing clinical trial. Intercept is a biopharmaceutical company that focuses on developing and commercializing therapeutics to treat progressive non-viral...

Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD), a condition in which fat builds up in a person's liver. As noted by the National Institute of Diabetes and Digestive and Kidney Diseases, there are no approved medicines to treat NAFLD and NASH. In a...

Allergan plc Ordinary Shares (NYSE: AGN)'s acquisition of Tobira Therapeutics Inc (NASDAQ: TBRA) has some analysts wondering: if Allergan is willing to pay a massive 500 percent premium for Tobira, then what could possibly come next? Barrons cited Kevin Kedra, an analyst at Gabelli, who...

Allergan plc Ordinary Shares (NYSE: AGN) paid a hefty premium of 159 percent to acquire Vitae Pharmaceuticals Inc (NASDAQ: VTAE) last week, but that figure pales in comparison to the premium attached to its acquisition of Tobira Therapeutics Inc (NASDAQ: TBRA). Allergan will pay $533 million in...

Shares of Tobira Therapeutics Inc (NASDAQ: TBRA) soared higher by more than 700 percent on Tuesday after the company was acquired by Allergan plc Ordinary Shares (NYSE: AGN). The massive premium Allergan is paying in Tobira's stock price has many investors questioning if any of Tobira's peers are...

Tobira Therapeutics Inc (NASDAQ: TBRA), a clinical-stage bio-pharmaceutical company that focuses on the development of therapies to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, soared higher by more than 760 percent on Tuesday after the company agreed to sell itself to...

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) shares have declined 63.88 percent over the past six months, reaching a low of $99.32 on January 28. Morgan Stanley’s Andrew S. Berens has upgraded the rating on the company from Underweight to Equal-Weight, with a price target of $100....

The Nashville Area ETF (NYSE: NASH), courtesy of LocalShares, commenced trading Thursday, marking the debut of the first city-specific ETF in the U.S. After just one trading day, it is too early to pass judgment on NASH. It may be debatable that Nashville, Tennessee would have been the first...

Exchange traded funds sponsor LocalShares will introduce the first city-specific ETF when the Nashville Area ETF (NYSE: NASH) debuts Thursday. NASH will track the LocalShares Nashville Index. The new fund has an annual expense ratio of 0.49 percent. "The LocalShares Nashville Index is comprised...